Linzess令澤舒

Linzess

Manufacturer:

Ironwood

Distributor:

Zuellig

Marketer:

AstraZeneca
Concise Prescribing Info
Contents
Linaclotide
Indications/Uses
Symptomatic treatment of moderate to severe irritable bowel syndrome w/ constipation (IBS-C) in adults.
Dosage/Direction for Use
Administration
Should be taken on an empty stomach: Take at least 30 min before meals.
Contraindications
Hypersensitivity. Patients w/ known or suspected mechanical GI obstruction.
Special Precautions
Rule out organic diseases & establish diagnosis of moderate to severe IBS-C before use. Discontinue in prolonged (eg, >1 wk) or severe diarrhoea until resolved. Control electrolyte if prone to disturbance of water or electrolyte balance (eg, elderly, CV diseases, diabetes, HTN). Not recommended in chronic intestinal tract inflammatory conditions (eg, Crohn's disease & ulcerative colitis). Pregnancy & lactation. Childn <18 yr. Elderly >65 yr.
Adverse Reactions
Diarrhoea. Viral gastroenteritis, abdominal pain, flatulence, abdominal distension, dizziness.
Drug Interactions
Increased risk of diarrhoea w/ proton pump inhibitors, laxatives or NSAIDs. May reduce the efficacy of OCs & medicinal products absorbed in the intestinal tract w/ a narrow therapeutic index (eg, levothyroxine).
MIMS Class
Other Gastrointestinal Drugs
ATC Classification
A06AX04 - linaclotide ; Belongs to the class of other laxatives.
Presentation/Packing
Form
Linzess hard cap 290 mcg
Packing/Price
10's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in